NASDAQ:AKBA

Akebia Shares Bounce 12% After Volatile Session
····

Akebia Shares Bounce 12% After Volatile Session

Akebia Therapeutics shares rose 12% to $1.01 in late trading Wednesday, rebounding from a two-day slide on heavy volume. The move followed first-quarter results showing Vafseo revenue climbed to $15.8 million while Auryxia sales fell to $36.2 million. Total revenue dropped to $53.5 million, with a net loss of $9.1 million. Investors weighed Vafseo’s growth against declining Auryxia sales and generic competition.
May 21, 2026

Stock Market Today

  • Surge in Investor Demand Drives Lloyds Banking Shares Higher
    May 30, 2026, 2:12 AM EDT. Lloyds Banking Group Plc (LSE: LLOY) has become the most bought stock on AJ Bell's platform, capturing 15.91% of buyer interest, significantly outpacing the next closest stock. The bank's Q1 2026 underlying profit rose 31% to £2 billion, beating expectations, and it continued a £1.75 billion share buyback programme, purchasing £700 million in Q1 and 7.746 million shares recently from Goldman Sachs. Despite a modest share price gain of 2.93% last week versus the FTSE 100's 0.18%, the sudden surge in investor interest lacks a clear catalyst. Analysts note UK banks remain undervalued, presenting potential long-term opportunities amid global economic uncertainties.